A Study Evaluating the Safety and Efficacy of ENV-101 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John Huetsch, M.D.
Endeavor Biomedicines
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Liverpool, New South Wales, Australia
- Research Site
Benowa, Queensland, Australia
- Research Site
Box Hill, Victoria, Australia
- Research Site
Clayton, Victoria, Australia
- Research Site
Vancouver, British Columbia, Canada
- Research Site
Sherbrooke, Quebec, Canada
- Research Site
Batu Caves, Malaysia
- Research Site
Kota Bharu, Malaysia
- Research Sire
Kuala Lumpur, Malaysia
- Research Site
Kuala Lumpur, Malaysia
- Research Site
Kuala Lumpur, Malaysia
- Research Site
Monterrey, Nuevo León, Mexico
- Research Site
Monterrey, Nuevo León, Mexico
- Research Site
San Nicolás de los Garza, Nuevo León, Mexico
- Research Site
Chihuahua City, Mexico
- Research Site
Mexico City, Mexico
- Research Site
Mexico City, Mexico
- Research Site
Oaxaca City, Mexico
- Research Site
Puebla City, Mexico
- Research Site (namdong District)
Incheon, South Korea
- Research Site (bundang District)
Seongnam, South Korea
- Research Site (gangnam District)
Seoul, South Korea
- Research Site (seongbuk District)
Seoul, South Korea
- Research Site (songpa District)
Seoul, South Korea
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Aug 2021
- Primary completion
- 30 Nov 2023
- Completion
- 30 Nov 2023
- Last update posted
- 2 Dec 2024
- Registered enrollment
- 41
- Registry id
- NCT04968574
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.